Navigation Links
US Oncology to Report 2009 Second Quarter Operating Results
Date:7/21/2009

HOUSTON, July 21 /PRNewswire/ -- US Oncology, Inc. will announce its financial results for the second quarter of fiscal 2009 on Thursday, August 6, 2009.

A conference call and simultaneous webcast will be hosted by management at 11 a.m. ET following distribution of the earnings release. Additional information will be available on the company's Web site, www.usoncology.com, in the News Room on the day of the earnings announcement.

US/Canada Dial-in #: (877) 615-1716

Conference ID #: 21338788

Web Cast Link: This link gives participants access to the live and/or archived event. This URL can be distributed for posting on various websites, or for inclusion in email notifications.

http://event.meetingstream.com/r.htm?e=156790&s=1&k=4350D83CA16497EC227E65577AB21765

About US Oncology, Inc.

US Oncology, headquartered in The Woodlands, Texas works closely with physicians, manufacturers and payers to identify and deliver innovative services that enhance patient access to advanced cancer care. US Oncology supports one of the nation's foremost cancer treatment and research networks accelerating the availability and use of evidence-based medicine and shared best practices.

US Oncology's expertise in supporting most aspects of the cancer care delivery system - from drug development to distribution and outcomes measurement, enables the Company to help increase the efficiency and safety of cancer care. US Oncology is affiliated with 1,227 physicians operating
'/>"/>

SOURCE US Oncology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
2. ESMO, Oxford Journals and the Japanese Society of Medical Oncology announce collaboration
3. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference
4. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
5. US Oncology to Report 2007 Third Quarter Earnings Results
6. VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting
7. Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines
8. Varian Medical Systems Ranks First in Overall Service Performance in 2007 Survey of U.S. Radiation Oncology Professionals
9. Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting
10. Debiopharm and NanoCarrier Sign License and Supply Agreement for Dach-Platin Polymeric Micelle in Oncology
11. National Autism Association and Deirdre Imus Environmental Center for Pediatric Oncology Announce National Greening Your School Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... (PRWEB) September 02, 2014 Alliance Strategies ... and multi-channel email marketing is pleased to announce it ... Firearms & Freedom as well as ... represent more than one million concerned Americans who can ... , “We are honored to continue providing our ...
(Date:9/2/2014)... New research shows a novel polypill increases patient ... or heart attack, according to new study results ... Congress 2014 in Barcelona, Spain. According to Principal ... Sinai Heart at Icahn School of Medicine at ... Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in ...
(Date:9/2/2014)... at the University of California, San Diego School of ... of breast cancer. The findings, reported in the ... cause of breast cancer mortality worldwide. An estimated 40,000 ... 2014, according to the American Cancer Society. , "The ... found a way to target breast cancer metastasis through ...
(Date:9/2/2014)... Obesity is associated with many health risks, including heart ... found a possible way to mitigate one often-overlooked risk: ... study led by Sheldon H. Jacobson, a professor of ... obesity rates are associated with a decrease in seatbelt ... laws are in effect. , "Primary seatbelt laws lead ...
(Date:9/2/2014)... York, NY (PRWEB) September 02, 2014 ... Jackman Foundation (BJF), a children’s literacy organization that has ... in need since its founding in 2001, will host ... from 1 – 2:30 p.m. at Barnes & Noble ... Daniel Nigro, this free public event for children and ...
Breaking Medicine News(10 mins):Health News:ASG Continues to Bring New Lists to Market 2Health News:ASG Continues to Bring New Lists to Market 3Health News:New polypill increases heart attack patients' medication adherence 2Health News:New polypill increases heart attack patients' medication adherence 3Health News:Enzyme controlling metastasis of breast cancer identified 2Health News:Seatbelt laws encourage obese drivers to buckle up 2Health News:Brooke Jackman Foundation Hosts 5th Annual Read-A-Thon, A Celebration of Hope and Literacy in New York City to Commemorate 13th Anniversary of 9/11 2Health News:Brooke Jackman Foundation Hosts 5th Annual Read-A-Thon, A Celebration of Hope and Literacy in New York City to Commemorate 13th Anniversary of 9/11 3
... was on his way to becoming a lawyer says how a ... ice, and I went straight over backwards," he says. "I wasn’t ... blood coming out of my ears and my nose. I don’t ... that moment. ”Eric suffered a massive head injury. "My pain just ...
... that men who are angry or hostile should find a ... from an irregular // heart rhythm called atrial fibrillation. Atrial ... quiver instead of beating effectively. This can cause blood to ... Researchers say this is the first study to show these ...
... acid helps women reduce their risk of birth defects. ... stroke patients alive.// Researchers say about 31,000 stroke-related deaths ... prevented each year since fortification was implemented. ,Folic ... are at an increased risk for stroke and heart ...
... recent study, researchers say , 20 minutes on an exercise ... // than even minimally invasive procedures used to open blocked ... artery disease were randomized to either the daily exercise program ... angioplasty procedure where a tiny, flexible tube (stent) is used ...
... pills do not reduce the risk of heart disease and ... ,Researchers say their results show estrogen alone does not appear ... combination hormone therapy is believed to do. Estrogen also does ... cancer. Researchers say the hormone does appear to decrease the ...
... the most common cancer in men between ages 15 and ... simply to remove it. But the way it's removed, which ... man's life. About 3 percent of all men who have ... other. If both testicles are removed, they will have no ...
Cached Medicine News:
(Date:9/2/2014)... , September 2, 2014 ... by Transparency Market Research "Latin America Home Healthcare ... Therapeutic Home Healthcare Devices, Mobility Assist Devices and ... Respiratory Therapy, Infusion Therapy and Unskilled Home Healthcare ... and Forecast, 2014 - 2020" the Latin American ...
(Date:9/2/2014)... , Spanien, September 2, 2014 /PRNewswire/ ... auf dem ESC-Kongress 2014 präsentierte GARFIELD-AF-Register ... und Behandlungsergebnisse von schlaganfallgefährdeten Patienten in ... Die Daten der ... einer innovativen und unabhängigen Forschungsinitiative zur ...
(Date:9/2/2014)... 2, 2014 Particle Sciences, the leading CDMO ... in development and manufacturing capabilities with the addition of ... , Particle Sciences, Associate Director Clinical Production, "The company ... room square footage, equipment and staff across the board, ... now has over 6000ft 2 of operating cleanroom ...
Breaking Medicine Technology:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 6Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 2Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 3Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 4Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 5Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 6Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 7Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 8Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 9Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 10Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 11Particle Sciences Expands Drug Eluting Device Capabilities and Overall Clinical Trial Manufacturing Resources 2
... 14, 2011 The National Organization for Rare Disorders ... the U.S. Conference on Rare Diseases and Orphan Products ... in rare diseases or orphan products is invited. ... conference will be truly unique in that it will ...
... Pharmaceuticals, Inc. (NASDAQ: IDIX ), announced today that ... Global Life Sciences Conference on September 21, 2011 at 2:00 ... The live and archived webcast of the ... the Idenix Investor Center at www.idenix.com . Please log ...
Cached Medicine Technology:NORD and DIA to Host Conference on Rare Diseases and Orphan Products 2
The True Non-Compliant Balloon....
... Jude Medical® Pacing System Analyzer (PSA Wand), ... implantation testing, programming and interrogation of bradycardia ... easy-to-use accessory to the St. Jude Medical ... obtaining measurements of intrinsic P- and R-wave ...
... The Finnpipette BioControl multichannel ... features as the single ... handle fits all seven ... channel tip cone modules. ...
... Long series in colonies, rows, and microplatesthat ... the multichannel pipette is becoming an ever-increasing ... use) was the main reason that the ... 8- or 12-channel pipette provides effective, precise, ...
Medicine Products: